Findings

What do systematic reviews say?

4,811 questions · 70,850 findings · 5,139 reviews

Sort:Best matchNewestHighest certainty Download CSV

No studies found 15,174 · 21.4%GRADE not reported 6,479 · 9.1%Very low 17,330 · 24.5%Low 17,814 · 25.1%Moderate 11,056 · 15.6%High 2,997 · 4.2%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Intervention not reported

Brolucizumab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 154 participants
Moderate

Intervention not reported

Bevacizumab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 261 participants
Moderate

Intervention not reported

Ranibizumab deferred laser · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 136 participants
Moderate

Intervention not reported

Ranibizumab prompt laser · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 136 participants
Moderate

Intervention not reported

Laser · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 563 participants
Moderate

Intervention not reported

Aflibercept · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 2644 participants
Very low

Intervention not reported

Bevacizumab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 305 participants
Low

Intervention not reported

Brolucizumab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 368 participants
Low

Intervention not reported

Conbercept · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 125 participants
Very low

Intervention not reported

Brolucizumab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 154 participants
Low

Intervention not reported

Faricimab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 1262 participants
Low

Intervention not reported

Ranibizumab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
11 studies · 2065 participants
Low

Intervention not reported

Aflibercept · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 2701 participants
Very low

Intervention not reported

Bevacizumab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 310 participants
Low

Intervention not reported

Brolucizumab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 369 participants
Low

Intervention not reported

Conbercept · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 125 participants
Very low

Intervention not reported

Faricimab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 1262 participants
Low

Intervention not reported

Ranibizumab · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
11 studies · 1501 participants
Very low

Intervention not reported

Ranibizumab deferred laser · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 139 participants
Low

Intervention not reported

Ranibizumab prompt laser · people with diabetic macular oedema

1 finding from 1 review

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 287 participants
Very low